Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis

被引：0
|
作者：
Fenghua Gao
Tingting Zhang
Hengqi Liu
Wei Li
Xianming Liu
Lihua Qiu
Lanfang Li
Shiyong Zhou
Zhengzi Qian
Sitong Dong
Sai Zhao
Xianhuo Wang
Huilai Zhang
机构：
[1] the Sino-US Center for Lymphoma and Leukemia Research,Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Researc
[2] The Ingenuity Centre,Systematic Review Solutions Ltd
来源：
Annals of Hematology | 2022年 / 101卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2817 / 2817
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR PREVIOUSLY UNTREATED ITALIAN PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
    Bellone, M.
    Pradelli, L.
    Friggi, E.
    Caputo, A.
    VALUE IN HEALTH, 2019, 22 : S465 - S466
  • [32] POD24 and Serous Effusion Involvement Impact on Overall Survival in Follicular Lymphoma Attended at the National Cancer Institute in Mexico: A Survey of 370 Patients
    Cetina, Gilda
    Fernandez, Omar
    Aguilar, Isaac
    Gutierrez, Olga
    Candelaria, Myrna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S393 - S393
  • [33] Prediction of Early Disease Progression at 24 Months (POD24) Using Pre-Treatment Biopsies from Patients with Follicular Lymphoma (FL) Treated with Immunochemotherapy (IC)
    Wright, George W.
    Ramsower, Colleen A.
    Cerhan, James R.
    Novak, Anne J.
    Link, Brian K.
    Maurer, Matthew J.
    Mwangi, Raphael
    Rosenthal, Allison C.
    Habermann, Thomas M.
    Staudt, Lou
    Kridel, Robert
    Scott, David W.
    Steidl, Christian
    Rimsza, Lisa M.
    BLOOD, 2022, 140 : 6426 - 6427
  • [34] Follicular Lymphoma in a Single Cancer Center and Validation of FLIPI, FLIPI2, PRIMA and POD24 in Non- Caucasian Patients from Peru
    Vasquez, Jule F.
    Diaz, Alonso
    Mendoza, Any S.
    Barrionuevo, Carlos
    Samanez-Figari, Cesar
    BLOOD, 2021, 138
  • [35] Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis
    Younes, Anas
    John, Burke M.
    Diefenbach, Catherine S.
    Ferrari, Silvia
    Kahn, Cyrus
    Sharman, Jeffrey P.
    Tani, Monica
    Ujjani, Chaitra S.
    Vitolo, Umberto
    Yuen, Sam
    Woodard, Paul
    Mundt, Kirsten
    Fingerle-Rowson, Gunter
    Chitra, Surya
    Sellam, Gila
    Morariu-Zamfir, Rodica
    Gilbertson, Michael
    BLOOD, 2017, 130
  • [36] Effectiveness of Targeted Therapy in Patients With Previously Untreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
    Kawalec, Pawel
    Lopuch, Sylwia
    Mikrut, Alicja
    CLINICAL BREAST CANCER, 2015, 15 (02) : 90 - U181
  • [37] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zeng, Zhiyong
    Lin, Junfang
    Chen, Junmin
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 935 - 943
  • [38] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zhiyong Zeng
    Junfang Lin
    Junmin Chen
    Annals of Hematology, 2013, 92 : 935 - 943
  • [39] COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA IN GREECE
    Vellopoulou, K.
    Tzanetakos, C.
    Theodoropoulou, T.
    Akratos, A.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S38 - S38
  • [40] Epcoritamab SC With Rituximab plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma, Including Patients With POD24: Updated Results From EPCORE NHL-2
    Merryman, Reid W.
    Belada, David
    Sureda, Anna
    Leppa, Sirpa
    Vermaat, Joost S. P.
    Holte, Harald
    Hutchings, Martin
    Lugtenburg, Pieternella
    de Vos, Sven
    Abrisqueta, Pau
    Nijland, Marcel
    Christensen, Jacob Haaber
    Wahlin, Bjorn E.
    Linton, Kim M.
    Wang Liwei
    Abbas, Aqeel
    Rana, Ali
    Quadri, Syed
    Falchi, Lorenzo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S37 - S38
12345